{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:52:27Z","timestamp":1791589947595,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.taap.2018.01.023","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:23:19Z","timestamp":1517394199000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-\u03baB activation and acceleration of intrinsic myelin repair"],"prefix":"10.1016","volume":"342","author":[{"given":"Nima","family":"Sanadgol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Golab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mostafaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mehdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Khalseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Vakilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghorban","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.taap.2018.01.023_bb0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10517-015-2903-z","article-title":"Cuprizone model as a tool for preclinical studies of the efficacy of multiple sclerosis diagnosis and therapy","volume":"159","author":"Abakumova","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.taap.2018.01.023_bb0010","first-page":"66","article-title":"On the mechanism of action of triptolide, beyond the NF-kB pathway","volume":"47","author":"Annereau","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2018.01.023_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.fct.2016.12.008","article-title":"Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells","volume":"100","author":"Baeeri","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2018.01.023_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.02.049","article-title":"ADAM12 is expressed by astrocytes during experimental demyelination","volume":"1326","author":"Baertling","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0025","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0014-4886(03)00347-9","article-title":"The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors","volume":"184","author":"Blakemore","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.taap.2018.01.023_bb0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-\u03baB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.taap.2018.01.023_bb0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/cdd.2014.35","article-title":"Tumor necrosis factor-\u03b1 impairs oligodendroglial differentiation through a mitochondria-dependent process","volume":"21","author":"Bonora","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2018.01.023_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1084\/jem.20041918","article-title":"Inhibition of astroglial NF-kappaB reduces inflammation and improves functional recovery after spinal cord injury","volume":"202","author":"Brambilla","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.taap.2018.01.023_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","article-title":"Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination","volume":"124","author":"Bruck","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2018.01.023_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","article-title":"Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination","volume":"48","author":"Buschmann","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-\u03baB as a therapeutic target in neurodegenerative diseases","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.taap.2018.01.023_bb0060","article-title":"Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's disease","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.taap.2018.01.023_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092325","article-title":"Human astrocytes: secretome profiles of cytokines and chemokines","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neures.2006.02.013","article-title":"Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes","volume":"55","author":"Dai","year":"2006","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.taap.2018.01.023_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.23174","article-title":"Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss","volume":"91","author":"Doan","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2018.01.023_bb0080","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1007\/s12035-015-9205-3","article-title":"Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders?","volume":"53","author":"Ettle","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.taap.2018.01.023_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.taap.2018.01.023_bb0090","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10571-013-9975-y","article-title":"Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes","volume":"33","author":"Goldberg","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.taap.2018.01.023_bb0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-4159.2008.05653.x","article-title":"Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia","volume":"107","author":"Gong","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2018.01.023_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-444-52001-2.00010-8","article-title":"The epidemiology of multiple sclerosis: insights to disease pathogenesis","volume":"122","author":"Goodin","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"10","key":"10.1016\/j.taap.2018.01.023_bb0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4161\/cc.4.10.2047","article-title":"The two faces of NF-kB in cell survival responses","volume":"4","author":"Graham","year":"2005","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.taap.2018.01.023_bb0110","first-page":"1","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"13","author":"Gudi","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"4","key":"10.1016\/j.taap.2018.01.023_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cytogfr.2006.04.005","article-title":"Alternative pathways of NF-\u03baB activation: a double-edged sword in health and disease","volume":"17","author":"Gutian","year":"2006","journal-title":"Cytokines Growth Factors"},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2009.10.016","article-title":"In toxic demyelination oligodendroglial cell death occurs early and is FAS independent","volume":"37","author":"Hesse","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.taap.2018.01.023_bb0125","doi-asserted-by":"crossref","DOI":"10.1042\/AN20120062","article-title":"Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination","volume":"4","author":"Hibbits","year":"2012","journal-title":"ASN Neuro"},{"key":"10.1016\/j.taap.2018.01.023_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resp.2012.01.016","article-title":"Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats","volume":"182","author":"Hung-Fu","year":"2012","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.taap.2018.01.023_bb0135","first-page":"1395","article-title":"Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappaB signaling pathway","volume":"11","author":"Jin","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.taap.2018.01.023_bb0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2018.01.023_bb0145","first-page":"2666","article-title":"Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells","volume":"8","author":"Kiviharju","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2018.01.023_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2009.08.017","article-title":"Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-\u03baB\/I\u03baB\u03b1 transcriptional complex","volume":"217","author":"Kizelsztein","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.taap.2018.01.023_bb0155","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","article-title":"To be, or not to be: NF-\u03baB is the answer-role of Rel\/NF-\u03baB in the regulation of apoptosis","volume":"22","author":"Kucharczak","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2018.01.023_bb0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor-kB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.taap.2018.01.023_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2018.01.023_bb0170","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.phymed.2012.02.014","article-title":"Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21","volume":"19","author":"Liu","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2018.01.023_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2015.10.051","article-title":"Oligodendrocyte progenitor programming and reprogramming: toward myelin regeneration","volume":"1638","author":"Lopez Juarez","year":"2016","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.taap.2018.01.023_bb0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.taap.2018.01.023_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2011.05.013","article-title":"Immunology meets neuroscience-opportunities for immune intervention in neurodegenerative diseases","volume":"26","author":"Lynch","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.taap.2018.01.023_bb0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.phytochem.2007.02.021","article-title":"Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii","volume":"68","author":"Ma","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.taap.2018.01.023_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn0203-105","article-title":"Insulating axons via NF-\u03baB","volume":"6","author":"Mattson","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.taap.2018.01.023_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI11916","article-title":"NF-kappaB in neuronal plasticity and neurodegenerative disorders","volume":"107","author":"Mattson","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.taap.2018.01.023_bb0205","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbi.2012.07.007","article-title":"CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved","volume":"26","author":"Murta","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.taap.2018.01.023_bb0210","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","article-title":"The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia","volume":"32","author":"Pasquini","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.taap.2018.01.023_bb0220","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.1006301107","article-title":"CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination","volume":"107","author":"Patel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2018.01.023_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.taap.2018.01.023_bb0230","first-page":"10","article-title":"MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages","volume":"12","author":"Premkumar","year":"2011","journal-title":"BMC Chem. Biol."},{"key":"10.1016\/j.taap.2018.01.023_bb0235","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/brain\/awq359","article-title":"IkappaB kinase 2 determines oligodendrocyte loss by noncell- autonomous activation of NF-kappaB in the central nervous system","volume":"134","author":"Raasch","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bjid.2012.09.008","article-title":"Evaluation of reactive Epstein\u2013Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS)","volume":"17","author":"Ramroodi","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.taap.2018.01.023_bb0245","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/08820139.2015.1085391","article-title":"Prophylactic effect of BIO-1211 small-molecule antagonist of VLA-4 in the EAE mouse model of multiple sclerosis","volume":"44","author":"Ramroodi","year":"2015","journal-title":"Immunol. Investig."},{"issue":"6","key":"10.1016\/j.taap.2018.01.023_bb0250","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bbi.2012.01.016","article-title":"Central nervous system: a modified immune surveillance circuit?","volume":"26","author":"Romo-Gonz\u00e1lez","year":"2012","journal-title":"Brain Behav. Immunol."},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0255","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5114\/aoms.2012.28544","article-title":"Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs)","volume":"8","author":"Sanadgol","year":"2012","journal-title":"Arch. Med. Sci."},{"issue":"12","key":"10.1016\/j.taap.2018.01.023_bb0265","first-page":"24","article-title":"Ellagic acid ameliorates cuprizone-induced acute CNS inflammation via restriction of microgliosis and down-regulation of CCL2 and CCL3 pro-inflammatory chemokines","volume":"62","author":"Sanadgol","year":"2016","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"issue":"13","key":"10.1016\/j.taap.2018.01.023_bb0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/1389450118666161108124414","article-title":"Recent updates in imperative natural compounds for healthy brain and nerve function: a systematic review of implications for multiple sclerosis","volume":"18","author":"Sanadgol","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.taap.2018.01.023_bb0270","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/13880209.2017.1319867","article-title":"Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12\/IL-17\/IL-11 axis and restriction of mature oligodendrocytes apoptosis","volume":"55","author":"Sanadgol","year":"2017","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.taap.2018.01.023_bb0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/brain\/aws262","article-title":"Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination","volume":"136","author":"Skripuletz","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.taap.2018.01.023_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1073858413504466","article-title":"Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators","volume":"20","author":"Sofroniew","year":"2014","journal-title":"Neuroscientist"},{"issue":"6","key":"10.1016\/j.taap.2018.01.023_bb0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of NF-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.taap.2018.01.023_bb0290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3892\/ijo.2013.1843","article-title":"Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis","volume":"42","author":"Tan","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.taap.2018.01.023_bb0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/bmc-2014-0015","article-title":"Mechanisms of remyelination: recent insight from experimental models","volume":"5","author":"Tanaka","year":"2014","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.taap.2018.01.023_bb0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.taap.2018.01.023_bb0305","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1242\/dmm.018218","article-title":"Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD","volume":"7","author":"Wang","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"8","key":"10.1016\/j.taap.2018.01.023_bb0310","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0463.2012.02882.x","article-title":"The cuprizone model: regional heterogeneity of pathology","volume":"120","author":"Wergeland","year":"2012","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.taap.2018.01.023_bb0315","first-page":"141","article-title":"Triptolide attenuates oxidative stress, NF-Kb activation and multiple cytokine gene expression in murine peritoneal macrophage","volume":"17","author":"Wu","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2018.01.023_bb0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-015-0275-y","article-title":"EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation","volume":"12","author":"Zhang","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.taap.2018.01.023_bb0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cns.12039","article-title":"Triptolide with potential medicinal value for diseases of the CNS","volume":"19","author":"Zheng","year":"2013","journal-title":"CNS Neurosci. Ther."}],"updated-by":[{"DOI":"10.1016\/j.taap.2026.118078","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000}}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T16:34:48Z","timestamp":1530549288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18300309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":65,"alternative-id":["S0041008X18300309"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.023","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-\u03baB activation and acceleration of intrinsic myelin repair","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}